Literature DB >> 3475161

Acute promyelocytic leukemia with t(15;17) and t(2;17;15).

O W Bjerrum, P Philip, T Pressler, I Tygstrup.   

Abstract

Cytogenetic examination in a case of acute promyelocytic leukemia (FAB-M3) demonstrated a stem line with t(15;17) and a side line with t(2;17;15). This observation indicates either clonal evolution from the standard translocation or a de novo complicated translocation. Previous cases with three-way translocations in acute promyelocytic leukemia have been reviewed. Three-way translocations seem to occur with similar frequency in M2 and M3 types of acute myeloid leukemia and in chronic myelocytic leukemia.

Entities:  

Mesh：

Year:  1987        PMID： 3475161     DOI： 10.1016/0165-4608(87)90359-1

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN： 0165-4608


  4 in total

1.  A PML/RARA chimeric gene on chromosome 12 in a patient with acute promyelocytic leukemia (M4) associated with a new variant translocation: t(12;15;17)(q24;q24;q11).

Authors:  Ayda Bennour; Ikram Tabka; Yosra Ben Youssef; Monia Zaier; Sondess Hizem; Abderrahim Khelif; Ali Saad; Halima Sennana
Journal:  Med Oncol       Date:  2013-01-06       Impact factor: 3.064

2.  A complex translocation (3;17;15) in acute promyelocytic leukemia confirmed by fluorescence in situ hybridization.

Authors:  Yanming Wang; Junjie Ma; Xinguang Liu; Riming Liu; Lingling Xu; Li Wang; Jiannong Cen; Xiaoxia Chu
Journal:  Oncol Lett       Date:  2016-10-18       Impact factor: 2.967

3.  A new three-way variant t(15;22;17)(q22;q11.2;q21) in acute promyelocytic leukemia.

Authors:  Takayasu Kato; Akira Hangaishi; Motoshi Ichikawa; Toru Motokura; Tsuyoshi Takahashi; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2009-02-04       Impact factor: 2.490

4.  Coexistence of t(15;17) and t(15;16;17) detected by fluorescence in situ hybridization in a patient with acute promyelocytic leukemia: A case report and literature review.

Authors:  Rui Zhang; Young-Mi Kim; Xianfu Wang; Yan Li; Hui Pang; Ji-Yun Lee; Shibo Li
Journal:  Oncol Lett       Date:  2014-07-02       Impact factor: 2.967
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.